Moderna pushes for vaccine approval as efficacy hits 100% in prevention of severe cases

Moderna Inc. has said it will apply for US and European emergency authorisation of its COVID-19 vaccine on Monday based on full results from a late-stage study showing its vaccine was 100 percent effective in preventing severe cases and 94.1 percent on the regular. The filing sets Moderna’s product up to be the second vaccine…

This content is for

  • Standard Bi-Annual, Premium Bi-Annual, Standard Yearly, Premium Yearly, Staff, 2 Weeks FREE plan, Standard Bi-Annual USD, Standard Yearly USD, Premium Bi-Annual USD, Premium Yearly USD, BusinessDay/Ready Set Work Premium Yearly (FREE), 2 Weeks FREE plan (Flutterwave), 2 Weeks FREE plan (Paylater), 2 Weeks FREE plan (Union Bank), 2 Weeks FREE plan (NAIJASTARTUP), Premium Yearly (Union Bank), 2 Weeks FREE plan (She Leads Africa), 2 Weeks FREE plan (PiggyVest), Combo offer with print, 2 Weeks FREE plan (Wema Bank), Standard Yearly- Welcome Back Package, Premium Yearly (CFA Society Nigeria ), Monthly Plan , USD monthly, Campus/Student Plan, $3.99 for 2 months, 1 Month Free , N500 for 1 month**, Standard Monthly, Test Free Card, Delay Sub testing, Test Free Trial, Student Yearly, Premium Monthly, 14 Days Free Trial, 30 Days Free Trial, and TEST paystack

members only. Visit the site and log in/register to read.

Find more latest news and headlines from the newspaper